Nyxoah Revenue and Competitors

Mont-Saint-Guibert,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Nyxoah's estimated annual revenue is currently $43.7M per year.(i)
  • Nyxoah's estimated revenue per employee is $251,000

Employee Data

  • Nyxoah has 174 Employees.(i)
  • Nyxoah grew their employee count by 4% last year.

Nyxoah's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, US OperationsReveal Email/Phone
3
General CounselReveal Email/Phone
4
VP Research And DevelopmentReveal Email/Phone
5
VP Marketing & Market DevelopmentReveal Email/Phone
6
ControllerReveal Email/Phone
7
VP OperationsReveal Email/Phone
8
Chief Technology OfficerReveal Email/Phone
9
Sr. Director Market DevelopmentReveal Email/Phone
10
Data Protection Officer (DPO) - Senior Legal ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Nyxoah?

Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Nyxoah's team is driven by the vision that OSA sufferers should benefit from the latest and greatest innovations, for better health outcomes, higher patient comfort and quality of life. At the heart of Nyxoah's innovation is a unique neurostimulation technology with more than 160 patents submitted worldwide. Nyxoah therapy will offer: - Unparalleled clinical efficacy - Increased patient comfort, therapy compliance and quality of life - Minimally invasive approach, thus streamlining patient flow and reducing surgery related risks - Positive health economics outcomes by reducing the burden of OSA and its comorbidities

keywords:N/A

N/A

Total Funding

174

Number of Employees

$43.7M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nyxoah News

2022-04-19 - Nyxoah (NASDAQ:NYXH) Coverage Initiated by Analysts at ...

Nyxoah logo Oppenheimer initiated coverage on shares of Nyxoah (NASDAQ:NYXH – Get Rating) in a note issued to investors on Wednesday,...

2022-03-22 - Nyxoah Reports Full Year 2021 Operating and Financial Results

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea...

2022-03-22 - Nyxoah SA (NYXH) Q4 2021 Earnings Call Transcript

Welcome to the Nyxoah full year 2021 earnings conference call. [Operator instructions] I would now like to hand the conference over to your...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$72M26613%N/A
#2
$138.7M451-1%N/A
#3
$81.7M503-1%N/A